Key Financial Data Of Reporting Company

Modalis Therapeutics Corporation - Filing #7272022

Concept As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
Key financial data of reporting company
Business results of reporting company
Ordinary profit (loss)
-1,439,929,000 JPY
-1,303,099,000 JPY
-2,351,788,000 JPY
-2,401,016,000 JPY
-1,995,790,000 JPY
-2,089,875,000 JPY
-1,277,595,000 JPY
-1,231,299,000 JPY
-439,549,000 JPY
-467,548,000 JPY
Profit (loss)
-1,441,083,000 JPY
-2,402,547,000 JPY
-2,586,894,000 JPY
-793,047,000 JPY
-468,758,000 JPY
Share capital
1,758,987,000 JPY
1,217,652,000 JPY
2,094,767,000 JPY
2,744,447,000 JPY
2,707,320,000 JPY
Total number of issued shares
69,403,998 xbrli:shares
33,355,272 xbrli:shares
29,362,500 xbrli:shares
28,967,500 xbrli:shares
28,515,600 xbrli:shares
Net assets
3,420,278,000 JPY
3,548,078,000 JPY
1,380,422,000 JPY
1,380,824,000 JPY
2,941,232,000 JPY
2,943,201,000 JPY
5,446,692,000 JPY
5,549,212,000 JPY
6,165,582,000 JPY
6,206,857,000 JPY
Total assets
3,468,695,000 JPY
3,691,549,000 JPY
2,025,925,000 JPY
1,820,138,000 JPY
3,129,833,000 JPY
2,972,850,000 JPY
5,921,792,000 JPY
6,069,137,000 JPY
6,196,133,000 JPY
6,277,017,000 JPY
Net assets per share
48.97
50.81
40.59
40.61
99.53
99.59
188.03
191.57
216.22
217.67
Dividend paid per share
Interim dividend paid per share
Basic earnings (loss) per share
-31.24
-28.57
-77.24
-77.59
-92.85
-88.88
-27.58
-25.70
-17.02
-17.79
Diluted earnings per share
Equity-to-asset ratio
0.980 xbrli:pure
0.955 xbrli:pure
0.668 xbrli:pure
0.744 xbrli:pure
0.934 xbrli:pure
0.984 xbrli:pure
0.920 xbrli:pure
0.914 xbrli:pure
0.995 xbrli:pure
0.989 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Payout ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-1,432,005,000 JPY
-2,254,466,000 JPY
-1,895,773,000 JPY
-747,466,000 JPY
-376,575,000 JPY
Net cash provided by (used in) investing activities
-188,000 JPY
-39,699,000 JPY
-185,719,000 JPY
171,563,000 JPY
-830,310,000 JPY
Net cash provided by (used in) financing activities
3,044,985,000 JPY
1,216,451,000 JPY
63,683,000 JPY
72,633,000 JPY
2,777,992,000 JPY
Cash and cash equivalents
3,575,277,000 JPY
1,883,437,000 JPY
2,933,162,000 JPY
4,936,193,000 JPY
5,421,476,000 JPY
Number of employees
4 xbrli:pure
4 xbrli:pure
4 xbrli:pure
14 xbrli:pure
37 xbrli:pure
3 xbrli:pure
36 xbrli:pure
3 xbrli:pure
3 xbrli:pure
26 xbrli:pure
3 xbrli:pure
20 xbrli:pure
Average number of temporary employees
1 xbrli:pure
1 xbrli:pure
1 xbrli:pure
1 xbrli:pure
1 xbrli:pure
1 xbrli:pure
1 xbrli:pure
1 xbrli:pure
1 xbrli:pure
1 xbrli:pure
1 xbrli:pure
2 xbrli:pure
Total shareholder return
0.046 xbrli:pure
0.056 xbrli:pure
0.151 xbrli:pure
0.277 xbrli:pure
xbrli:pure
Total return on share price index
0.538 xbrli:pure
0.590 xbrli:pure
0.610 xbrli:pure
0.826 xbrli:pure
xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.